These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16523070)

  • 61. Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?
    Preminger-Shapiro R; Nussinovitch M; Soen G; Varsano I
    Eur J Pediatr; 1995 Oct; 154(10):866-7. PubMed ID: 8529693
    [No Abstract]   [Full Text] [Related]  

  • 62. Immune globulin intravenous products--notice to hospitals.
    Hogan V
    CMAJ; 1999 Apr; 160(7):1051-2, 1055-6. PubMed ID: 10207352
    [No Abstract]   [Full Text] [Related]  

  • 63. Hepatitis C and immune globulin.
    Prince AM; Horowitz B
    N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract]   [Full Text] [Related]  

  • 64. Infectious hazards of immune globulin.
    Barton LL
    J Pediatr; 1995 Feb; 126(2):321-2. PubMed ID: 7844688
    [No Abstract]   [Full Text] [Related]  

  • 65. Correction: RSV immune globulin intravenous.
    Wandstrat TL
    Ann Pharmacother; 1997 May; 31(5):648-9. PubMed ID: 9161671
    [No Abstract]   [Full Text] [Related]  

  • 66. [Immunoglobulins and immune deficiency: methods of administration].
    Suarez F
    Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
    [No Abstract]   [Full Text] [Related]  

  • 67. Multiorgan failure induced by intravenous immunoglobulin.
    Ikeda M; Hamasaki Y; Hataya H; Honda M; Sugai K
    Acta Paediatr; 2000 Nov; 89(11):1393. PubMed ID: 11106058
    [No Abstract]   [Full Text] [Related]  

  • 68. Complications of intravenous immune globulin treatment in neurologic disease.
    Achiron A
    Neurology; 1997 Sep; 49(3):899-900. PubMed ID: 9305372
    [No Abstract]   [Full Text] [Related]  

  • 69. Impact of ideal body weight dosing for all inpatient i.v. immune globulin indications.
    Rocchio MA; Hussey AP; Southard RA; Szumita PM
    Am J Health Syst Pharm; 2013 May; 70(9):751-2. PubMed ID: 23592355
    [No Abstract]   [Full Text] [Related]  

  • 70. Administration of intravenous immunoglobulin to a patient with hypogammaglobulinemia and anti-IgA antibodies.
    Lieberman P; Rachid R
    J Allergy Clin Immunol Pract; 2013; 1(6):704. PubMed ID: 24565726
    [No Abstract]   [Full Text] [Related]  

  • 71. High-dose intravenous immune globulin for stiff-person syndrome.
    Dalakas MC; Fujii M; Li M; Lutfi B; Kyhos J; McElroy B
    N Engl J Med; 2001 Dec; 345(26):1870-6. PubMed ID: 11756577
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go?
    Scott DE; Epstein JS
    Transfusion; 2015 Jul; 55 Suppl 2():S122-6. PubMed ID: 26174890
    [No Abstract]   [Full Text] [Related]  

  • 73. Polyvalent immune globulin usage by indication in the United States, 2012: a quantitative analysis of the use of polyvalent immune globulin (intravenous and subcutaneous) by medical indication in the United States in 2012.
    Robert P; Hotchko M
    Transfusion; 2015 Jul; 55 Suppl 2():S6-12. PubMed ID: 26174899
    [No Abstract]   [Full Text] [Related]  

  • 74. Safety of intravenous immunoglobulin treatment.
    Caress JB; Kennedy BL; Eickman KD
    Expert Opin Drug Saf; 2010 Nov; 9(6):971-9. PubMed ID: 20408737
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
    Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B
    Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous immunoglobulin induced meningoencephalitis.
    Nooraine J; Iyer RB; Raghavendra S
    Neurol India; 2014; 62(1):98-9. PubMed ID: 24608480
    [No Abstract]   [Full Text] [Related]  

  • 77. VI nerve palsy after intravenous immunoglobulin in Kawasaki disease.
    Rodríguez-Lozano A; Juárez-Echenique JC; Rivas-Larrauri F; Gámez-González LB; Yamazaki-Nakashimada M
    Allergol Immunopathol (Madr); 2014; 42(1):82-3. PubMed ID: 23340202
    [No Abstract]   [Full Text] [Related]  

  • 78. Intravenous immunoglobulin infusion causing pseudohyponatremia.
    Ng SK
    Lupus; 1999; 8(6):488-90. PubMed ID: 10483022
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 80. Hepatitis associated with high dose intravenous gammaglobulin.
    Craig TJ; Davis W
    Ann Allergy; 1993 Sep; 71(3):276. PubMed ID: 8373001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.